Preclinical evaluation of ZL006-05, a new antistroke drug with fast-onset antidepressant and anxiolytic effects
Work
Year: 2023
Type: article
Abstract: Background Poststroke depression and anxiety, independent predictor of poor functional outcomes, are common in the acute phase of stroke. Up to now, there is no fast-onset antidepressive and anxiolyti... more
Source: Stroke and Vascular Neurology
Cites: 40
Cited by: 8
Related to: 10
FWCI: 1.951
Citation percentile (by year/subfield): 99.98
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $1,839
Funders National Natural Science Foundation of China, National Natural Science Foundation of China, National Natural Science Foundation of China
Grant IDS 81870912, 82090042, 82171293